West Pharmaceutical Services Inc. buy Bank of America Co.
Start price
16.06.23
/
50%
€336.30
Target price
16.06.24
€369.72
Performance (%)
-6.69%
End price
17.06.24
€313.80
Summary
This prediction ended on 17.06.24 with a price of €313.80. With a performance of -6.69%, the BUY prediction by Bank_of_America_Co_ finished with a loss. Dividends of €0.73 are taken into consideration when calculating the performance. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -7.054% | -7.054% | 29.768% | -10.068% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by Bank_of_America_Co_ for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $405.00 price target on the stock, up previously from $390.00.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€310.30
13.12.24
13.12.24
€338.21
13.12.25
13.12.25
-27.10%
14.12.25
14.12.25
